Nektar Therapeutics
NKTR
$1.47
Share price
11.26%
Change (1 day)
95.81%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - Net assets
Net assets on the balance sheet as of December 2023 : $0.13 B
According to Nektar Therapeutics
's latest financial reports the company has $0.13 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Nektar Therapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.13 B | -64.27% |
| 2022-12-31 | $0.36 B | -46.04% |
| 2021-12-31 | $0.67 B | -36.92% |
| 2020-12-31 | $1.07 B | -23.35% |
| 2019-12-31 | $1.40 B | -18.18% |
| 2018-12-31 | $1.71 B | 1855.61% |
| 2017-12-31 | $87.82 M | -0.34% |
| 2016-12-31 | $88.12 M | 1270.74% |
| 2015-12-31 | $6.42 M | -82.3% |
| 2014-12-31 | $36.33 M | -140.41% |
| 2013-12-31 | $-89.91 M | -291.21% |
| 2012-12-31 | $47.01 M | -76.23% |
| 2011-12-31 | $0.19 B | 118.19% |
| 2010-12-31 | $90.66 M | -11.43% |
| 2009-12-31 | $0.10 B | -46.17% |
| 2008-12-31 | $0.19 B | -11.32% |
| 2007-12-31 | $0.21 B | -5.56% |
| 2006-12-31 | $0.22 B | -30.52% |
| 2005-12-31 | $0.32 B | -30.07% |
| 2004-12-31 | $0.46 B | 184.63% |
| 2003-12-31 | $0.16 B | -20.59% |
| 2002-12-31 | $0.20 B | -23.51% |
| 2001-12-31 | $0.27 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 52,404.45% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | 68,065.54% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 4,657.72% | 🇺🇸 USA |
 Baxter BAX | $8.46 B | 6,364.76% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 28,631.86% | 🇺🇸 USA |
 AstraZeneca AZN | $37.50 B | 28,529.56% | 🇬🇧 UK |
 Richardson Electronics RELL | $0.15 B | 21.10% | 🇺🇸 USA |
 Alkermes ALKS | $1.20 B | 818.18% | 🇮🇪 Ireland |